Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors.
Clinical & translational immunology
View this publicationClinical & translational immunology
View this publicationJAMA oncology
View this publicationImmunology and cell biology
View this publicationNature communications
View this publicationCancer research
View this publicationJNCI cancer spectrum
View this publicationImmunity
View this publicationScientific reports
View this publicationCell reports
View this publicationSeminars in cancer biology
View this publication